Our team
Dan Stoicescu, PhD
Chief Executive Office, Founder
Dan brings over 30 years of pharmaceutical and business experience in the field of drug discovery and development. He leads the design of Floratek’s pipeline of small molecules and the creation of the company’s intellectual property. Before founding Floratek, Dan founded and led for over 15 years Sindan AG, an oncology holding sold in 2006 to Actavis Group. Dan holds a PhD in Medicinal Chemistry from the University of Bucharest.
Mauro Angiolini, PhD
Associate Scientific Director
Mauro is a medicinal chemist and biotech entrepreneur with long experience in small molecule oncology drug discovery for precision medicine. He was the Founder and Managing Director of Eudendron Srl and inventor of a first-in-class MPS1 inhibitor in Phase II trials. He is an expert in structure-based drug design, investor relations, and strategic R&D. Mauro holds a PhD in Medicinal Chemistry from the University of Milan.
Paulina Biniecka, PhD
Associate Director
Paulina is a highly skilled cancer biologist with over 5 years of research experience on diverse cancer models. She got her Master degree in Pharmaceutical Sciences at Copenhagen University, specializing in drug development, then completed her PhD in Life Sciences at the University of Lausanne, with research on anticancer therapies.